Skip to main content
. Author manuscript; available in PMC: 2014 Jan 2.
Published in final edited form as: Curr Cancer Drug Targets. 2013 May;13(4):411–422. doi: 10.2174/1568009611313040005

Figure 1. MS-275 sensitizes OS cells to FasL-induced cell death.

Figure 1

LM7 and CCH-OS-D cells were treated with 2 μM MS-275 for 48 hours with or without 10 ng/ml sFasL for 24 hours. Drug was removed at the end of the treatment period and replaced with fresh medium. Cytotoxicity was quantified 15 days later by counting colonies following crystal violet staining. Colonies were counted as 50 cells per colony. *P < 0.05 compared to control and either agent alone, n=3.